|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Apollo Endosurgery, Inc (APEN) |
|
|
$10.00 0.00 (0.00%) as of 4:30 Mon 4/3
|
|
Download |
|
|
| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
46,334,000 |
| Market
Cap: |
463.34(M) |
| Last
Volume: |
221,296 |
Avg
Vol: |
220,684 |
| 52
Week Range: |
$10 - $10 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Apollo Endosurgery is a holding company. Through its subsidiaries, Co. is a medical technology company primarily focused on the design, development and commercialization of medical devices to develop gastrointestinal (GI) therapeutic endoscopy. Co.'s products are used by gastroenterologists and bariatric surgeons in a variety of settings to treat various GI conditions including closure of acute perforations and chronic fistulas; inadvertent perforation of the GI tract; tissue closure after the removal of abnormal lesions in the esophagus, stomach or colon; the treatment of swallowing disorders (peroral endoscopic myotomy); esophageal stent fixation and obesity.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Newton Todd |
Chief Executive Officer |
• • – |
2017-05-16 |
4 |
B |
$6.12 |
$5,502 |
D/D |
899 |
29,544 |
2.81 |
- |
|
| Mcclellan William D. Jr. |
Director |
– • – |
2017-05-16 |
4 |
B |
$6.19 |
$1,857 |
I/I |
300 |
300 |
2.02 |
- |
|
| Novo A/s |
10% Owner |
– – • |
2017-05-11 |
4 |
S |
$5.62 |
$582,094 |
D/D |
(103,500) |
1,351,972 |
|
- |
|
| Novo A/s |
10% Owner |
– – • |
2017-05-10 |
4 |
S |
$5.74 |
$8,609 |
D/D |
(1,500) |
1,455,472 |
|
- |
|
| Gostout Christopher J. |
Chief Medical OfficerOfficer |
• – – |
2017-01-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,811 |
|
- |
|
| Novo A/s |
10% Owner |
– – • |
2016-12-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,456,972 |
|
- |
|
| Anderson Rick D |
Director |
– • • |
2016-12-29 |
4 |
A |
$0.00 |
$0 |
I/I |
4,152,463 |
605,712 |
|
- |
|
| Meelia Richard J |
Director |
– • – |
2016-12-29 |
4 |
A |
$0.00 |
$0 |
I/I |
17,501 |
17,501 |
|
- |
|
| Robertson Bruce C |
Director |
– • • |
2016-12-29 |
4 |
A |
$0.00 |
$0 |
I/I |
1,451,185 |
1,451,185 |
|
- |
|
| Crawford Matthew S |
Director |
– • – |
2016-12-29 |
4 |
A |
$0.00 |
$0 |
D/D |
4,152,463 |
605,712 |
|
- |
|
| Creecy John W |
Director |
– • • |
2016-12-29 |
4 |
A |
$0.00 |
$0 |
I/I |
1,309,392 |
1,309,392 |
|
- |
|
| Crawford Matthew S |
Director |
– • • |
2016-12-29 |
4 |
A |
$0.00 |
$0 |
I/I |
4,152,463 |
605,712 |
|
- |
|
| Mcgaughy R Kent Jr |
Director |
– • – |
2016-12-29 |
4 |
A |
$0.00 |
$0 |
I/I |
817,804 |
195,330 |
|
- |
|
| Cavanaugh Stefanie L. |
CFO, Treasurer, Secretary |
• – – |
2016-12-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,864 |
2,864 |
|
- |
|
| Mcwilliams Dennis L. |
President, CCO |
• – – |
2016-12-29 |
4 |
A |
$0.00 |
$0 |
D/D |
33,647 |
33,647 |
|
- |
|
| Newton Todd |
Chief Executive Officer |
• • – |
2016-12-29 |
4 |
A |
$0.00 |
$0 |
D/D |
28,645 |
28,645 |
|
- |
|
| Atkinson Gary J G |
CEO and CFO |
• – – |
2016-03-09 |
4 |
D |
$0.19 |
$632 |
D/D |
(3,325) |
32,116 |
|
- |
|
| Atkinson Gary J G |
CEO and CFO |
• – – |
2016-03-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,500 |
35,441 |
|
- |
|
| Petree Daniel H |
Director |
– • – |
2016-03-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,646 |
11,155 |
|
- |
|
| Swortwood Donald |
Director |
– • – |
2016-03-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,485 |
9,200 |
|
- |
|
| Mathews Charles |
Director |
– • – |
2016-03-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,485 |
19,916 |
|
- |
|
| Ferrell Jeffrey |
Director |
– • – |
2016-03-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,485 |
12,486 |
|
- |
|
| Petree Daniel H |
Director |
– • – |
2015-09-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
794 |
6,509 |
|
- |
|
| Ferrell Jeffrey |
Director |
– • – |
2015-04-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,715 |
9,001 |
|
- |
|
| Swortwood Donald |
Director |
– • – |
2015-04-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,715 |
5,715 |
|
- |
|
209 Records found
|
|
Page 8 of 9 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
